- On-going trials- We are participating in a number of on-going trials designed for the improvement of women’s cancer. Please contact us or check your eligibility before enrolling in a particular study.
- INTERLACE Trial: Webpage for interlace
- SENTICOL Trial: Webpage(short summary from Interlace official webpage)
Upcoming Trials: We are planning a number of upcoming trials on ovarian and endometrial cancers. Please contact us or check your eligibility before enrolling in a particular study. Webpage will be updated soon.
- HOTROC – Hormonal Therapy in Recurrent Ovarian Cancer
- HIPEC-HR- HIPEC in Homologous recombination (HR) stratified ovarian cancer
- IPIROC- Intermittent PARP inhibitor in Recurrent Ovarian Cancer
- PREGNANCY- Peripartum PREvention of Gynecological MaligNANCY and PRATIMA –PRAgmaTIc PrevenTIve Approaches in Gynecological MAlignancy
- BIODIVARSITY-BRCAness In Breast and Ovarian Cancer: Impact of Diverse Arsenic Exposure in India in causaTion and PrevenTion strategY
- NuGenA- NUrse led GENetic counselling and Awareness for women’s cancer
| HEPTROC (Health economic evaluation of primary treatment for ovarian cancer) | PDF Download |
| KolGo PROVAR 001 - HIPEC in Homologous Recombination Stratified Ovarian Cancer(HR-HIPEC) | PDF Download |
| KolGo PROVAR 002- Intermittent PARP Inhibitor in Recurrent Ovarian Cancer (IPIROC) | PDF Download |
| KolGo PROVAR 003- Hormone Therapy in Recurrent Ovarian Cancer(HOTROC) | PDF Download |
| KolGo PROVAR 004- NUrse GENetic counsellor led community health campaign on Awareness of hereditary women’s cancer in India (NuGenA) | PDF Download |
| KolGo PROVAR 005- BRCAness In Breast and Ovarian Cancer- Impact of Diverse Arsenic Exposure in India in causaTion and PrevenTion strategY(BIODIVARSITY) | PDF Download |
| Restrictive or individualized Goal directed fluid replacemnet strategy in Ovarian cancer cytoreductive surgery- a prospective randomised control trial | PDF Download |